152 related articles for article (PubMed ID: 36869866)
1. Function and regulation of GPR84 in human neutrophils.
Forsman H; Dahlgren C; Mårtensson J; Björkman L; Sundqvist M
Br J Pharmacol; 2024 May; 181(10):1536-1549. PubMed ID: 36869866
[TBL] [Abstract][Full Text] [Related]
2. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the pro-inflammatory G protein-coupled receptor GPR84.
Marsango S; Milligan G
Br J Pharmacol; 2024 May; 181(10):1500-1508. PubMed ID: 37085331
[TBL] [Abstract][Full Text] [Related]
4. Biased agonists of GPR84 and insights into biological control.
Luscombe VB; Wang P; Russell AJ; Greaves DR
Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.
Sundqvist M; Christenson K; Holdfeldt A; Gabl M; Mårtensson J; Björkman L; Dieckmann R; Dahlgren C; Forsman H
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):695-708. PubMed ID: 29477577
[TBL] [Abstract][Full Text] [Related]
6. GPR84 in physiology-Many functions in many tissues.
Aktar R; Rondinelli S; Peiris M
Br J Pharmacol; 2024 May; 181(10):1524-1535. PubMed ID: 37533166
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84.
Marsango S; Barki N; Jenkins L; Tobin AB; Milligan G
Br J Pharmacol; 2022 Jul; 179(14):3529-3541. PubMed ID: 32869860
[TBL] [Abstract][Full Text] [Related]
8. GRK2 selectively attenuates the neutrophil NADPH-oxidase response triggered by β-arrestin recruiting GPR84 agonists.
Fredriksson J; Holdfeldt A; Mårtensson J; Björkman L; Møller TC; Müllers E; Dahlgren C; Sundqvist M; Forsman H
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119262. PubMed ID: 35341806
[TBL] [Abstract][Full Text] [Related]
9. Editorial for GPR84 pharmacology.
Milligan G
Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
[TBL] [Abstract][Full Text] [Related]
10. Hydroxycarboxylic acid receptor 3 and GPR84 - Two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells.
Peters A; Rabe P; Liebing AD; Krumbholz P; Nordström A; Jäger E; Kraft R; Stäubert C
Pharmacol Res; 2022 Feb; 176():106047. PubMed ID: 34968686
[TBL] [Abstract][Full Text] [Related]
11. The PAR4-derived pepducin P4Pal
Holdfeldt A; Lind S; Hesse C; Dahlgren C; Forsman H
Biochem Pharmacol; 2020 Oct; 180():114143. PubMed ID: 32653592
[TBL] [Abstract][Full Text] [Related]
12. Larixol is not an inhibitor of Gα
Björkman L; Forsman H; Bergqvist L; Dahlgren C; Sundqvist M
Biochem Pharmacol; 2024 Feb; 220():115995. PubMed ID: 38151076
[TBL] [Abstract][Full Text] [Related]
13. The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.
Holdfeldt A; Skovbakke SL; Winther M; Gabl M; Nielsen C; Perez-Gassol I; Larsen CJ; Wang JM; Karlsson A; Dahlgren C; Forsman H; Franzyk H
J Biol Chem; 2016 Sep; 291(38):19888-99. PubMed ID: 27422818
[TBL] [Abstract][Full Text] [Related]
14. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
[TBL] [Abstract][Full Text] [Related]
15. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
[TBL] [Abstract][Full Text] [Related]
16. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
17. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
18. Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor.
Gaidarov I; Anthony T; Gatlin J; Chen X; Mills D; Solomon M; Han S; Semple G; Unett DJ
Pharmacol Res; 2018 May; 131():185-198. PubMed ID: 29471103
[TBL] [Abstract][Full Text] [Related]
19. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
20. Barbadin selectively modulates FPR2-mediated neutrophil functions independent of receptor endocytosis.
Sundqvist M; Holdfeldt A; Wright SC; Møller TC; Siaw E; Jennbacken K; Franzyk H; Bouvier M; Dahlgren C; Forsman H
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118849. PubMed ID: 32916203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
